Emerging mediators of airway smooth muscle dysfunction in asthma

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 1, 2013, Pages 105-111

  Yeganeh, Behzad ^a   Xia, Connie ^b   Movassagh, Hesam ^a   Koziol White, Cynthia ^c   Chang, Ying ^d   Al Alwan, Laila ^d   Bourke, Jane E ^b   Oliver, Brian G G ^e  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e University of Sydney   (Australia)

Author keywords

Airway smooth muscle; Asthma

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 8; SEMAPHORIN; SEMAPHORIN 7A; STAT3 PROTEIN; TOLL LIKE RECEPTOR 7; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AIRWAY REMODELING; AIRWAY SMOOTH MUSCLE DYSFUNCTION; ARTICLE; ASTHMA; CYTOKINE PRODUCTION; HUMAN; INFLAMMATORY CELL; INFLUENZA; MUSCLE DISEASE; MUSCLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; SIGNAL TRANSDUCTION; TH17 CELL; VIRUS INFECTION;

AIRWAY REMODELING; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHEMOKINES, CXC; CYTOKINES; HUMANS; INFLAMMATION; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHENOTYPE; SEMAPHORINS;

EID: 84873141271     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.06.011     Document Type: Article

References (123)

1. Koziol-White C.J., Panettieri R.A. Airway smooth muscle and immunomodulation in acute exacerbations of airway disease. Immunol Rev 2011, 242:178-185.
2. Ozier A., Allard B., Bara I., Girodet P.O., Trian T., Marthan R., et al. The pivotal role of airway smooth muscle in asthma pathophysiology. J Allergy (Cairo) 2011 2011, 742710.
3. Johnson P.R., Roth M., Tamm M., Hughes M., Ge Q., King G., et al. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001, 164:474-477.
4. Trian T., Benard G., Begueret H., Rossignol R., Girodet P.O., Ghosh D., et al. Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma. J Exp Med 2007, 204:3173-3181.
5. Johnson P.R., Burgess J.K., Underwood P.A., Au W., Poniris M.H., Tamm M., et al. Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism. J Allergy Clin Immunol 2004, 113:690-696.
6. Ward J.E., Hirst S.J. Airway smooth muscle regulation of matrix proteins & interactions with the extracellular matrix. Airway smooth muscle biology & Pharmacology in airways disease 2007, 105-126. John Wiley & Sons Ltd. K.F. Chung (Ed.).
7. Burgess J.K., Ceresa C., Johnson S.R., Kanabar V., Moir L.M., Nguyen Trang T.B., et al. Tissue and matrix influences on airway smooth muscle function. Pulmonary Pharmacology & Therapeutics 2009, 22:379-387.
8. Chan V., Burgess J.K., Ratoff J.C., O'Connor B.J., Greenough A., Lee T.H., et al. Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med 2006, 174:379-385.
9. Oliver B.G., Johnston S.L., Baraket M., Burgess J.K., King N.J., Roth M., et al. Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection. Respir Res 2006, 7:71.
10. Matsumoto H., Moir L.M., Oliver B.G., Burgess J.K., Roth M., Black J.L., et al. Comparison of gel contraction mediated by airway smooth muscle cells from patients with and without asthma. Thorax 2007, 62:848-854.
11. Ma X., Cheng Z., Kong H., Wang Y., Unruh H., Stephens N.L., et al. Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. American Journal of Physiology - Lung Cellular and Molecular Physiology 2002, 283:L1181-L1189.
12. Mauad T., Bel E.H., Sterk P.J. Asthma therapy and airway remodeling. J Allergy Clin Immunol 2007, 120:997-1009. quiz 1010-1001.
13. Bentley J.K., Hershenson M.B. Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration. Proc Am Thorac Soc 2008, 5:89-96.
14. Boulet L., Belanger M., Carrier G. Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction. Am J Respir Crit Care Med 1995, 152:865-871.
15. Bai T.R., Cooper J., Koelmeyer T., Pare P.D., Weir T.D. The effect of age and duration of disease on airway structure in fatal asthma. Am J Respir Crit Care Med 2000, 162:663-669.
16. Lange P., Parner J., Vestbo J., Schnohr P., Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998, 339:1194-1200.
17. Olson T.S., Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002, 283:R7-28.
18. Strieter R.M., Burdick M.D., Gomperts B.N., Belperio J.A., Keane M.P. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 2005, 16:593-609.
19. Kramp B.K., Sarabi A., Koenen R.R., Weber C. Heterophilic chemokine receptor interactions in chemokine signaling and biology. Exp Cell Res 2011, 317:655-663.
20. Smith D.F., Galkina E., Ley K., Huo Y. GRO family chemokines are specialized for monocyte arrest from flow. Am J Physiol Heart Circ Physiol 2005, 289:H1976-H1984.
21. Ahuja S.K., Murphy P.M. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 1996, 271:20545-20550.
22. DiStasi M.R., Ley K. Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol 2009, 30:547-556.
23. Reich N., Beyer C., Gelse K., Akhmetshina A., Dees C., Zwerina J., et al. Microparticles stimulate angiogenesis by inducing ELR(+) CXC-chemokines in synovial fibroblasts. J Cell Mol Med 2011, 15:756-762.
24. Goleva E., Hauk P.J., Hall C.F., Liu A.H., Riches D.W., Martin R.J., et al. Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J Allergy Clin Immunol 2008, 122:550-559. e553.
25. Jones C.P., Pitchford S.C., Lloyd C.M., Rankin S.M. CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling. Stem Cells 2009, 27:3074-3081.
26. Jarai G., Sukkar M., Garrett S., Duroudier N., Westwick J., Adcock I., et al. Effects of interleukin-1beta, interleukin-13 and transforming growth factor-beta on gene expression in human airway smooth muscle using gene microarrays. Eur J Pharmacol 2004, 497:255-265.
27. Issa R., Xie S., Lee K.Y., Stanbridge R.D., Bhavsar P., Sukkar M.B., et al. GRO-alpha regulation in airway smooth muscle by IL-1beta and TNF-alpha: role of NF-kappaB and MAP kinases. Am J Physiol Lung Cell Mol Physiol 2006, 291:L66-L74.
28. Al-Alwan L.A., Chang Y., Baglole C.J., Risse P.A., Halayko A.J., Martin J.G., et al. Autocrineregulated airway smooth muscle cell migration is dependent on IL-17-induced growth-related oncogenes. J Allergy Clin Immunol 2012.
29. Sauty A., Dziejman M., Taha R.A., Iarossi A.S., Neote K., Garcia-Zepeda E.A., et al. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 1999, 162:3549-3558.
30. Brightling C.E., Ammit A.J., Kaur D., Black J.L., Wardlaw A.J., Hughes J.M., et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 2005, 171:1103-1108.
31. Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes 1997, 246-257.
32. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark Lewis I., et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996, 184:963-969.
33. Brightling C.E., Kaur D., Berger P., Morgan A.J., Wardlaw A.J., Bradding P. Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration. J Leukoc Biol 2005, 77:759-766.
34. Lin Y., Yan H., Xiao Y., Piao H., Xiang R., Jiang L., et al. Attenuation of antigen-induced airway hyperresponsiveness and inflammation in CXCR3 knockout mice. Respir Res 2011, 12:123.
35. Medoff B.D., Sauty A., Tager A.M., Maclean J.A., Smith R.N., Mathew A., et al. IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J Immunol 2002, 168:5278-5286.
36. Kurashima K., Fujimura M., Myou S., Ishiura Y., Onai N., Matsushima K. Asthma severity is associated with an increase in both blood CXCR3+ and CCR4 + T cells. Respirology 2006, 11:152-157.
37. Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., Pavord I.D. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002, 346:1699-1705.
38. Ammit A.J., Bekir S.S., Johnson P.R., Hughes J.M., Armour C.L., Black J.L. Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi. Am J Respir Crit Care Med 1997, 155:1123-1129.
39. Carroll N.G., Mutavdzic S., James A.L. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J 2002, 19:879-885.
40. Bradding P., Walls A.F., Holgate S.T. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 2006, 117:1277-1284.
41. Berger P., Compton S.J., Molimard M., Walls A.F., N'Guyen C., Marthan R., et al. Mast cell tryptase as a mediator of hyperresponsiveness in human isolated bronchi. Clin Exp Allergy 1999, 29:804-812.
42. Panettieri R.A., Yadvish P.A., Kelly A.M., Rubinstein N.A., Kotlikoff M.I. Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression. Am J Physiol 1990, 259:L365-L371.
43. Brown J.K., Jones C.A., Tyler C.L., Ruoss S.J., Hartmann T., Caughey G.H. Tryptase-induced mitogenesis in airway smooth muscle cells. Potency, mechanisms, and interactions with other mast cell mediators. Chest 1995, 107:95S-96S.
44. Hirst S.J., Barnes P.J., Twort C.H. PDGF isoform-induced proliferation and receptor expression in human cultured airway smooth muscle cells. Am J Physiol 1996, 270:L415-L428.
45. Johnson P.R., Armour C.L., Carey D., Black J.L. Heparin and PGE2 inhibit DNA synthesis in human airway smooth muscle cells in culture. Am J Physiol 1995, 269:L514-L519.
46. Hawker K.M., Johnson P.R., Hughes J.M., Black J.L. Interleukin-4 inhibits mitogen-induced proliferation of human airway smooth muscle cells in culture. Am J Physiol 1998, 275:L469-L477.
47. Parameswaran K., Cox G., Radford K., Janssen L.J., Sehmi R., O'Byrne P.M., et al. Cysteinyl leukotrienes promote human airway smooth muscle migration. Am J Respir Crit Care Med 2002, 166:738-742.
48. Parameswaran K., Radford K., Fanat A., Stephen J., Bonnans C., Levy B.D., et al. Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines. Am J Respir Cell Mol Biol 2007, 37:240-247.
49. Xia Y., Powell M., Harris T., Stewart A.G., Mackay G.A. Secreted Factors from Human Mast Cells Trigger Inflammatory Cytokine Production from Human Airway Smooth Muscle Cells. Am J Respir Crit Care Med 2011, 183.
50. Xia Y.C., Sun S., Kuek L.E., Lopata A.L., Hulett M.D., Mackay G.A. Human mast cell line-1 (HMC-1) cells transfected with FcepsilonRIalpha are sensitive to IgE/ antigen-mediated stimulation demonstrating selectivity towards cytokine production. Int Immunopharmacol 2011, 11:1002-1011.
51. John M., Au B.T., Jose P.J., Lim S., Saunders M., Barnes P.J., et al. Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am J Respir Cell Mol Biol 1998, 18:84-90.
52. Makinde T., Murphy R.F., Agrawal D.K. The regulatory role of TGF-beta in airway remodeling in asthma. Immunol Cell Biol 2007, 85:348-356.
53. Woodman L., Siddiqui S., Cruse G., Sutcliffe A., Saunders R., Kaur D., et al. Mast cells promote airway smooth muscle cell differentiation via autocrine upregulation of TGF-beta 1. J Immunol 2008, 181:5001-5007.
54. Grunstein M.M., Hakonarson H., Leiter J., Chen M., Whelan R., Grunstein J.S., et al. IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2002, 282:L520-L528.
55. Venkayya R., Lam M., Willkom M., Grunig G., Corry D.B., Erle D.J. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 2002, 26:202-208.
56. Bradding P., Holgate S.T. Immunopathology and human mast cell cytokines. Crit Rev Oncol Hematol 1999, 31:119-133.
57. Cruse G., Kaur D., Yang W., Duffy S.M., Brightling C.E., Bradding P., et al. Activation of human lung mast cells by monomeric immunoglobulin E. Eur Respir J 2005, 25:858-863.
58. Loetscher P., Pellegrino A., Gong J.H., Mattioli I., Loetscher M., Bardi G., et al. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem 2001, 276:2986-2991.
59. Suzaki Y., Hamada K., Nomi T., Ito T., Sho M., Kai Y., et al. A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation. Eur Respir J 2008, 31:783-789.
60. Kolodkin A.L., Matthes D.J., Goodman C.S. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 1993, 75:1389-1399.
61. Roth L., Koncina E., Satkauskas S., Cremel G., Aunis D., Bagnard D. The many faces of semaphorins: from development to pathology. Cell Mol Life Sci 2009, 66:649-666.
62. Al-Muhsen S., Johnson J.R., Hamid Q. Remodeling in asthma. J Allergy Clin Immunol 2011, 128:451-462. quiz 463-454.
63. Capparuccia L., Tamagnone L. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment-two sides of a coin. J Cell Sci 2009, 122:1723-1736.
64. Ahmed A., Eickholt B.J. Intracellular kinases in semaphorin signaling. Adv Exp Med Biol 2007, 600:24-37.
65. Page K., Li J., Hodge J.A., Liu P.T., Vanden Hoek T.L., Becker L.B., et al. Characterization of a Rac1 signaling pathway to cyclin D(1) expression in airway smooth muscle cells. J Biol Chem 1999, 274:22065-22071.
66. Sakata Y., Xiang F., Chen Z., Kiriyama Y., Kamei C.N., Simon D.I., et al. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro. Arterioscler Thromb Vasc Biol 2004, 24:2069-2074.
67. Spindler V., Schlegel N., Waschke J. Role of GTPases in control of microvascular permeability. Cardiovasc Res 2010, 87:243-253.
68. Gan Y., Reilkoff R., Peng X., Russell T., Chen Q., Mathai S.K., et al. Role of semaphorin 7a signaling in transforming growth factor β1-induced lung fibrosis and scleroderma-related interstitial lung disease. Arthritis Rheum 2011, 63:2484-2494.
69. Kang H.R., Lee C.G., Homer R.J., Elias J.A. Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis. J Exp Med 2007, 204:1083-1093.
70. Casazza A., Fu X., Johansson I., Capparuccia L., Andersson F., Giustacchini A., et al. Systemic and targeted delivery of semaphorin 3A inhibits tumor angiogenesis and progression in mouse tumor models. Arterioscler Thromb Vasc Biol 2011, 31:741-749.
71. Potiron V.A., Sharma G., Nasarre P., Clarhaut J.A., Augustin H.G., Gemmill R.M., et al. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells. Cancer Res 2007, 67:8708-8715.
72. Sawaki H., Nakamura F., Aihara M., Nagashima Y., Komori-Yamaguchi J., Yamashita N., et al. (2011) Intranasal Administration of Semaphorin-3A Alleviates Sneezing and Nasal Rubbing in a Murine Model of Allergic Rhinitis. J Pharmacol Sci. 2011, 117(1):34-44.
73. Smith E.P., Shanks K., Lipsky M.M., DeTolla L.J., Keegan A.D., Chapoval S.P. Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor. BMC Immunol 2011, 12:30.
74. Nkyimbeng-Takwi E.H., Shanks K., Smith E., Iyer A., Lipsky M.M., Detolla L.J., et al. Neuroimmune semaphorin 4A downregulates the severity of allergic response. Mucosal Immunol 2012, 5(4):409-419.
75. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003, 278:1910-1914.
76. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
77. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006, 203:2271-2279.
78. Kolls J.K., Linden A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
79. Liang S.C., Long A.J., Bennett F., Whitters M.J., Karim R., Collins M., et al. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 2007, 179:7791-7799.
80. Wright J.F., Guo Y., Quazi A., Luxenberg D.P., Bennett F., Ross J.F., et al. Identification of an interleukin 17F/17A heterodimer in activated human CD4 + T cells. J Biol Chem 2007, 282:13447-13455.
81. Stark M.A., Huo Y., Burcin T.L., Morris M.A., Olson T.S., Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005, 22:285-294.
82. Huber M., Heink S., Grothe H., Guralnik A., Reinhard K., Elflein K., et al. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity. Eur J Immunol 2009, 39:1716-1725.
83. Lluis A., Schedel M., Liu J., Illi S., Depner M., von Mutius E., et al. Asthma-associated polymorphisms in 17q21 influence cord blood ORMDL3 and GSDMA gene expression and IL-17 secretion. J Allergy Clin Immunol 2011, 127:1587-1594. e1586.
84. Zhao Y., Yang J., Gao Y.D., Guo W. Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol 2010, 151:297-307.
85. Al-Ramli W., Prefontaine D., Chouiali F., Martin J.G., Olivenstein R., Lemière C., et al. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol 2009, 123:1185-1187.
86. Sergejeva S., Ivanov S., Lotvall J., Linden A. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am J Respir Cell Mol Biol 2005, 33:248-253.
87. Roussel L., Houle F., Chan C., Yao Y., Berube J., Olivenstein R., et al. IL-17 promotes p38 MAPKdependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 2010, 184:4531-4537.
88. Prause O., Bozinovski S., Anderson G.P., Linden A. Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax 2004, 59:313-317.
89. Linden A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol 2001, 126:179-184.
90. Rahman M.S., Yang J., Shan L.Y., Unruh H., Yang X., et al. IL-17R activation of human airway smooth muscle cells induces CXCL-8 production via a transcriptional- dependent mechanism. Clin Immunol 2005, 115:268-276.
91. Chang Y., Al-Alwan L., Risse P.A., Roussel L., Rousseau S., Halayko A.J., et al. TH17 cytokines induce human airway smooth muscle cell migration. J Allergy Clin Immunol 2011, 127:e1041-e1042. 1046-53.
92. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004, 21:241-254.
93. Wuyts W.A., Vanaudenaerde B.M., Dupont L.J., Van Raemdonck D.E., Demedts M.G., Verleden G.M. Interleukin-17-induced interleukin-8 release in human airway smooth muscle cells: role for mitogen-activated kinases and nuclear factor-kappaB. J Heart Lung Transplant 2005, 24:875-881.
94. Henness S., van Thoor E., Ge Q., Armour C.L., Hughes J.M., Ammit A.J. IL-17A acts via p38 MAPK to increase stability of TNF-alpha-induced IL-8 mRNA in human ASM. Am J Physiol Lung Cell Mol Physiol 2006, 290:L1283-L1290.
95. Dragon S., Rahman M.S., Yang J., Unruh H., Halayko A.J., Gounni A.S. IL-17 enhances IL-1beta-mediated CXCL-8 release from human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1023-L1029.
96. Henness S., Johnson C.K., Ge Q., Armour C.L., Hughes J.M., Ammit A.J. IL-17A augments TNF-alpha-induced IL-6 expression in airway smooth muscle by enhancing mRNA stability. J Allergy Clin Immunol 2004, 114:958-964.
97. Rahman M.S., Yamasaki A., Yang J., Shan L., Halayko A.J., Gounni A.S. IL-17A induces eotaxin-1/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1/2, JNK, and p38) pathways. J Immunol 2006, 177:4064-4071.
98. Saleh A., Shan L., Halayko A.J., Kung S., Gounni A.S. Critical role for STAT3 in IL-17A-mediated CCL11 expression in human airway smooth muscle cells. J Immunol 2009, 182:3357-3365.
99. Cheng S.S., Lukacs N.W., Kunkel S.L. Eotaxin/CCL11 suppresses IL-8/CXCL8 secretion from human dermal microvascular endothelial cells. J Immunol 2002, 168:2887-2894.
100. Cheng S.S., Lukacs N.W., Kunkel S.L. Eotaxin/CCL11 is a negative regulator of neutrophil recruitment in a murine model of endotoxemia. Exp Mol Pathol 2002, 73:1-8.
101. Lajoie S., Lewkowich I.P., Suzuki Y., Clark J.R., Sproles A.A., Dienger K., et al. Complementmediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol 2010, 11:928-935.
102. Wang Q., Li H., Yao Y., Xia D., Zhou J. The overexpression of heparin-binding epidermal growth factor is responsible for Th17-induced airway remodeling in an experimental asthma model. J Immunol 2010, 185:834-841.
103. Joubert P., Hamid Q. Role of airway smooth muscle in airway remodeling. J Allergy Clin Immunol 2005, 116:713-716.
104. Chaudhuri N., Whyte M.K., Sabroe I. Reducing the toll of inflammatory lung disease. Chest 2007, 131:1550-1556.
105. Sukkar M.B., Xie S., Khorasani N.M., Kon O.M., Stanbridge R., Issa R., et al. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol 2006, 118:641-648.
106. Cooper P.R., Lamb R., Day N.D., Branigan P.J., Kajekar R., San Mateo L., et al. TLR3 activation stimulates cytokine secretion without altering agonist-induced human small airway contraction or relaxation. Am J Physiol Lung Cell Mol Physiol 2009, 297:L530-L537.
107. Clarke D., Damera G., Sukkar M.B., Tliba O. Transcriptional regulation of cytokine function in airway smooth muscle cells. Pulm Pharmacol Ther 2009, 22:436-445.
108. Morris G.E., Parker L.C., Ward J.R., Jones E.C., Whyte M.K., Brightling C.E., et al. Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses. FASEB J 2006, 20:2153-2155.
109. Elias J.A., Wu Y., Zheng T., Panettieri R. Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am J Physiol 1997, 273:L648-L655.
110. Hakonarson H., Carter C., Maskeri N., Hodinka R., Grunstein M.M. Rhinovirus-mediated changes in airway smooth muscle responsiveness: induced autocrine role of interleukin-1beta. Am J Physiol 1999, 277:L13-L21.
111. Bachar O., Adner M., Uddman R., Cardell L.O. Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways. Eur J Immunol 2004, 34:1196-1207.
112. Luo S.F., Wang C.C., Chiu C.T., Chien C.S., Hsiao L.D., Lin C.H., et al. Lipopolysaccharide enhances bradykinin-induced signal transduction via activation of Ras/Raf/MEK/MAPK in canine tracheal smooth muscle cells. Br J Pharmacol 2000, 130:1799-1808.
113. Ekman A.K., Adner M., Cardell L.O. Toll-like receptor 7 activation reduces the contractile response of airway smooth muscle. Eur J Pharmacol 2011, 652:145-151.
114. Grunstein M.M., Hakonarson H., Whelan R., Yu Z., Grunstein J.S., Chuang S. Rhinovirus elicits proasthmatic changes in airway responsiveness independently of viral infection. J Allergy Clin Immunol 2001, 108:997-1004.
115. Grunstein M.M., Hakonarson H., Maskeri N., Chuang S. Autocrine cytokine signaling mediates effects of rhinovirus on airway responsiveness. Am J Physiol Lung Cell Mol Physiol 2000, 278:L1146-L1153.
116. Hakonarson H., Maskeri N., Carter C., Hodinka R.L., Campbell D., Grunstein M.M. Mechanism of rhinovirus-induced changes in airway smooth muscle responsiveness. J Clin Invest 1998, 102:1732-1741.
117. Hakonarson H., Herrick D.J., Serrano P.G., Grunstein M.M. Autocrine role of interleukin 1beta in altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J Clin Invest 1997, 99:117-124.
118. Billington C.K., Pascual R.M., Hawkins M.L., Penn R.B., Hall I.P. Interleukin-1beta and rhinovirus sensitize adenylyl cyclase in human airway smooth-muscle cells. Am J Respir Cell Mol Biol 2001, 24:633-639.
119. Trian T., Moir L.M., Ge Q., Burgess J.K., Kuo C., King N.J., et al. Rhinovirus-induced exacerbations of asthma: how is the {beta}2-adrenoceptor implicated?. Am J Respir Cell Mol Biol 2010, 43:227-233.
120. Moore P.E., Cunningham G., Calder M.M., DeMatteo A.D., Peeples M.E., Summar M.L., et al. Respiratory syncytial virus infection reduces beta2-adrenergic responses in human airway smooth muscle. Am J Respir Cell Mol Biol 2006, 35:559-564.
121. Nagarkar D.R., Wang Q., Shim J., Zhao Y., Tsai W.C., Lukacs N.W., et al. CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection. J Immunol 2009, 183:6698-6707.
122. Bramley A.M., Vitalis T.Z., Wiggs B.R., Hegele R.G. Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea-pigs. Eur Respir J 1999, 14:1061-1067.
123. Hashimoto K., Peebles R.S., Sheller J.R., Jarzecka K., Furlong J., Mitchell D.B., et al. Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor. Thorax 2002, 57:524-527.